Fig. 6
From: First-in-class positron emission tomography tracer for the glucagon receptor

Human predicted dosimetry of [68Ga]Ga-DO3A-S01-GCG and [68Ga]Ga-DO3A-S02-GCG. The human predicted tissue-specific-absorbed dose and whole body effective dose of [68Ga]Ga-DO3A-S01-GCG and [68Ga]Ga-DO3A-S02-GCG (a). The maximal annual radioactive dosing possible of either radiotracer, based on the absorbed dose and the annual radiation safety limits (b). The renal dose was limiting for both [68Ga]Ga-DO3A-S01-GCG and [68Ga]Ga-DO3A-S02-GCG